We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
(+5.3%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$211M |
| 2 |
AbbVie
ABBV
|
+$176M |
| 3 |
Apple
AAPL
|
+$170M |
| 4 |
Nike
NKE
|
+$161M |
| 5 |
Coca-Cola
KO
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$221M |
| 2 |
Medtronic
MDT
|
+$163M |
| 3 |
UnitedHealth
UNH
|
+$148M |
| 4 |
Johnson & Johnson
JNJ
|
+$133M |
| 5 |
Pfizer
PFE
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Consumer Discretionary | 14.98% |
| 3 | Healthcare | 13.91% |
| 4 | Financials | 10.93% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGI
476
Somnigroup International
SGI
$14B
| $9.32M | 0.04% |
232,553
+118,898
| +105% | +$4.47M |
|
477
NovoCure
NVCR
$2.02B
| $9.22M | 0.04% |
222,207
+211,389
| +1,954% | +$13.1M |
|
478
Zillow
ZG
$8.15B
| $9.22M | 0.04% |
187,371
-57,028
| -23% | -$2.57M |
|
479
Telus
TU
$15.2B
| $9.2M | 0.04% |
472,594
-141,571
| -23% | -$2.85M |
|
|
EQC
480
DELISTED
Equity Commonwealth
EQC
| $9.19M | 0.04% |
453,690
-108,482
| -19% | -$2.25M |
|
481
Norwegian Cruise Line
NCLH
$8.99B
| $9.15M | 0.04% |
+420,473
| New | +$6.44M |
|
|
WRK
482
DELISTED
WestRock Company
WRK
| $9.15M | 0.04% |
314,721
+42,647
| +16% | +$1.24M |
|
483
Roivant Sciences
ROIV
$26.2B
| $9.15M | 0.04% |
907,561
-90,020
| -9% | -$805K |
|
484
Takeda Pharmaceutical
TAK
$55.6B
| $9.14M | 0.04% |
581,666
-435,102
| -43% | -$7.13M |
|
485
Teledyne Technologies
TDY
$31.2B
| $9.05M | 0.04% |
+22,015
| New | +$9.08M |
|
|
NVRO
486
DELISTED
NEVRO CORP.
NVRO
| $9.03M | 0.04% |
355,263
+119,952
| +51% | +$3.46M |
|
487
NNN REIT
NNN
$8.88B
| $9.02M | 0.04% |
210,858
+26,228
| +14% | +$1.13M |
|
488
Jones Lang LaSalle
JLL
$17B
| $9.02M | 0.04% |
57,873
-39,602
| -41% | -$5.62M |
|
489
DT Midstream
DTM
$13.8B
| $8.95M | 0.04% |
180,572
-81,111
| -31% | -$3.88M |
|
490
Service Corp International
SCI
$11.3B
| $8.94M | 0.04% |
138,423
+109,586
| +380% | +$7.32M |
|
491
Cboe Global Markets
CBOE
$30.7B
| $8.93M | 0.04% |
64,739
-122,180
| -65% | -$16.7M |
|
492
US Bancorp
USB
$102B
| $8.93M | 0.04% |
+270,157
| New | +$8.73M |
|
493
Generac Holdings
GNRC
$12.8B
| $8.92M | 0.04% |
59,823
-129,634
| -68% | -$14.8M |
|
494
Globe Life
GL
$14B
| $8.89M | 0.04% |
81,105
+65,386
| +416% | +$7.03M |
|
495
SSR Mining
SSRM
$6.49B
| $8.88M | 0.04% |
626,466
+50,066
| +9% | +$758K |
|
496
Par Pacific Holdings
PARR
$4.12B
| $8.87M | 0.04% |
333,163
+17,101
| +5% | +$404K |
|
497
Sprinklr
CXM
$1.65B
| $8.84M | 0.04% |
+639,496
| New | +$8.27M |
|
498
DHT Holdings
DHT
$3.09B
| $8.83M | 0.04% |
1,035,156
+254,210
| +33% | +$2.23M |
|
499
Harmony Biosciences
HRMY
$2.24B
| $8.8M | 0.04% |
250,122
+146,937
| +142% | +$5.07M |
|
500
Rockwell Automation
ROK
$49.5B
| $8.79M | 0.04% |
26,696
+12,552
| +89% | +$3.62M |
|
Similar funds
VAI
JG
Voloridge Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
- Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
- Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
- Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
- Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
- Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
- Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.
Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.